Mechanisms of Brain Signaling During Sepsis by Akrout, Najla et al.
296  Current Neuropharmacology, 2009, 7, 296-301   
  1570-159X/09 $55.00+.00  ©2009 Bentham Science Publishers Ltd. 
Mechanisms of Brain Signaling During Sepsis 
Najla Akrout, Tarek Sharshar and Djillali Annane
* 
General Intensive Care Unit, Raymond Poincaré Hospital (AP-HP), University of Versailles SQY (UniverSud Paris), 
104 boulevard Raymond Poincaré, 92380 Garches, France 
Abstract: Brain signaling is a crucial event for the body to mount an appropriate response to invading microorganisms. 
Pro-inflammatory cytokines are released from infected tissues and reach key structures in the brain via the circumven-
tricular organs, areas of damaged blood brain barrier or they cross actively the blood brain barrier using specific carriers. 
Alternately, cytokines may activate brain endothelial cells or microglial to produce prostaglandins which then diffuse into 
the brain to activate neurons. Finally, cytokines may activate the autonomic nervous system at the periphery. The follow-
ing  crosstalk  between  astrocytes  and  microglial  precedes  neuronal  activation  particularly  within  the  hippocampus, 
amygdale and hypothalamus. The resulting release of neuro-hormones in the systemic circulation allows restoration of 
homeostasis. It is likely that an excess in nitric oxide and complement anaphylatoxin C5a contributes to DNA damage 
within neurons of the hippocampus and hypothalamus and subsequent brain dysfunction. 
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INTRODUCTION 
  Sepsis is a clinical syndrome that reflects an uncontrolled 
systemic  inflammatory  response  to  an  infection.  This  syn-
drome usually includes a source of infection, and at least two 
of the four signs of a systemic inflammatory response syn-
drome  (SIRS):  fever  or  hypothermia,  tachycardia,  rapid 
breathing,  hyperleucocytosis  or  leucopoenia.  When  the  in-
flammatory response is sustained, patients will develop or-
gan dysfunction, shock and may die. This disease still places 
a burden to the healthcare system worldwide with an annual 
incidence of about 200 cases per 100000 in-habitants and a 
mortality rate of 25%, and up to 60% when shock is present 
[1,52]. 
  An altered mental status is a common feature of severe 
sepsis,  and  is  termed  sepsis  associated  encephalopathy,  or 
sepsis associated delirium [56,58]. Indeed, the neurological 
manifestations may variably include delirium, agitation and 
coma.  Sometimes  brain  dysfunction  is  more  subtle,  or 
masked by sedative drugs, and can be evidenced only using 
electrophysiological testing, or more cumbersome examina-
tions for intensive care unit patients, such as magnetic reso-
nance imaging showing structural abnormalities [58]. There 
is enough evidence to suggest that the more severe the en-
cephalopathy the lower the survival chance [24,56].  
  The brain is highly protected from the rest of the body 
and  particularly  from  the  blood  and  potential  circulating 
products. The brain plays also a major role in orchestrating 
host response to stress like infection. In this review we will 
summarize  how  brain  is  activated  following  infection,  its 
subsequent normal response, and we will discuss potential 
mechanisms that may cause central nervous system failure 
and ensuing progression of inflammation to death.  
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SIGNALING PATHWAYS  
  The  vagus  nerve  and  circumventricular  organs  (CVOs) 
are  the  two  main  pathways  to  signal  the  brain  during  in-
flammation and sepsis whereas peripheral cortisol exerts  a 
negative feedback.  
  The  vagus  nerve  is  a  sensor  of  visceral  inflammation 
through its axonal cytokine receptors. It is comprised of non-
myelinated  fibers  with  free  nerve  endings.  These  terminal 
parts of the vagus nerve are sensitive to mechanical states of 
the viscera and local changes in the chemical environment. 
Afferent vagal fibers terminate  in the nucleus tractus soli-
tarius which controls the baroreflex and is connected to other 
autonomic  structures  and  to  paraventricular  nuclei  of  the 
hypothalamus.  
  The circumventricular organs are discrete central nervous 
system sites that lack a blood brain barrier. Some of them are 
located in the vicinity of neuroendocrine structures (e.g., the 
neurohypophysis,  vascular  organ  of  the  lamina  terminalis, 
subfornical  organs,  pineal  gland,  and  subcommissural  or-
gan), others are close to brainstem autonomic centers (i.e., 
area postrema). The circumventricular organs express com-
ponents of innate and adaptative immune systems, such as 
toll-like receptors, CD14, and cytokine receptors including 
receptors  to  interleukin  (IL)  1β,  IL  6,  and  tumor  necrosis 
factor (TNF) α (pro-inflammatory cytokines that induce fe-
ver, activate the neuroendocrine and autonomic centers) [15].  
KEY  BRAIN  SYSTEMS  INVOLVED  IN  THE  RE-
SPONSE TO SEVERE INFECTIONS 
  Three main systems are tightly interconnected to orches-
trate  homeostasis  in  stressful  conditions  such  as  sepsis, 
trauma or surgery. These structures include: the limbic sys-
tem (mainly the hippocampus and amygdala), the hypotha-
lamic-pituitary axis and the Locus Coeruleus / noradrenergic 
system (Fig. 1).  
  The limbic system is comprised of four main structures, 
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septal area. The amygdala is connected to the hippocampus, 
septal nuclei, and prefrontal areas and to the medial dorsal 
nucleus of the thalamus. It plays a major role for the identifi-
cation  of  danger  and  self  preservation.  Stimulation  of  the 
amygdala results  in anxiety and fear, with  alertness  and  a 
stage of being ready to fly or fight. Inhibition of amygdala 
neurons renders the body indifferent to danger. The hippo-
campus is mainly responsible for long term memory; it al-
lows the comparison of present stress with similar past expe-
riences, enabling the choice of an appropriate response to the 
stress  for  surviving.  In  animals,  hippocampus  lesions  may 
result in thymic atrophy and decreased lymphocytes counts 
suggesting immune-suppression [10]. Activation of the hip-
pocampus suppresses corticotropin releasing hormone (CRH) 
synthesis  [61].  Because  no  direct  anatomical  substrate
  be-
tween  hippocampus/cortex  and  hypothalamic  parvocellular 
neurons have
 yet been successfully identified, it is likely that 
cortico-hippocampal
  influences  on  hypothalamic  hypo-
physiotropic neurons are indirectly achieved
 via subcortical 
relay neurons. The hypothalamus is organized into three re-
gions including the lateral, medial and periventricular hypo-
thalamus, each having distinct morphological and functional 
features.  The  paraventricular  nuclei  are  localized  in  the 
periventricular hypothalamus. It is organized into three cellu-
lar divisions: a medial group that produces CRH and releases 
it into the hypophysial portal system; an intermediate group 
 
that secretes vasopressin in association with the supra optic 
nuclei to be stored in the posterior pituitary gland; a lateral 
group that produces CRH and innervates noradrenergic neu-
rons in the brain stem. Hypothalamic derived peptides that 
stimulate  the  pituitary  gland  include  CRH,  LH-releasing 
hormone, FSH-releasing factor, GH-releasing factor, prolactin 
stimulating factor and thyrotropin –releasing hormone. Other 
peptides  are  inhibiting  factors  like  GH-inhibiting  hormone 
(somatostatin)  and  PRL-inhibiting  hormone.  Vasopressin, 
natriuretic  peptides,  and  catecholamines  also  influence  the 
pituitary function by direct action on the gland. The effect of 
CRH on ACTH release by  the pituitary is permissive and 
vasopressin acts in synergy with CRH. There are tight inter-
connections between projections of CRH –synthesizing neu-
rons from the parvocellular nuclei to the brain stem and re-
ciprocally  noradrenergic  projections  originating  from  the 
Locus Coeruleus, located in the rostral pons and controlling 
arousal  and  cardiovascular  autonomic  centers,  and  ending 
with synapse on cholinergic inter-neurons in the parvocellu-
lar nuclei. Thereby, noradrenaline, CRH and vasopressin can 
stimulate  each  other.  Through  collateral  fibers,  ultra  short 
negative feedback loops allow permanent adaptation of the 
synergy between the two systems [12]. Finally, CRH, vaso-
pressin and noradrenaline are on the stimulatory control of 
the  serotoninergic,  cholinergic  and  histaminergic  systems 
and are inhibited by the gamma amino butyric acid, benzodi- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Key structures involved in brain signalling during severe infections. Invading microorganisms result in release of pro-inflammatory 
cytokines that enter the brain through CVOs lacking a blood brain barrier, through areas where the blood brain barrier is breakdown, or via 
active transport across the blood brain barrier. In addition, afferent vagal fibres are activated via cytokines receptors at the level of peripheral 
tissue. Red colour indicates activating signals to the brain. Blue colour indicates negative controls. BBB CVOs = circumventricular organs. 
CRF= corticotrophin releasing factor – AVP = vasopressin. 298    Current Neuropharmacology, 2009, Vol. 7, No. 4  Akrout et al. 
azepine and opioids systems. The limbic, hypothalamic, and 
noradrenergic systems fine-tune each other to maintain ho-
meostasis in presence of a stressor. 
CYTOKINES TRAFFICKING TO THE BRAIN 
  Invading  microorganisms  are  recognized  by  immune 
cells  through  a  number  of  molecular  pattern  recognition 
molecules. The subsequent activation of immune cells results 
in the release of pro-inflammatory cytokines within the focus 
of infection and in the arterial circulation [1]. It is now rec-
ognized that increase in cytokine concentrations, e.g. IL-1, in 
the periphery increases the turnover of noradrenaline in the 
hypothalamus  [16,17]  and  increases  peripheral  plasma  [4] 
and  brain  [16]  noradrenaline  metabolism  and  extracellular 
levels.  Similarly,  intracerebroventricular  and  peripheral  in-
jection of interferon (IFN)-α or IL-1β produces a sustained 
increase of the sympathetic activity of the splenic nerve and 
increases the turnover of NE in the spleen [30]. Brain ex-
pression of pro-inflammatory cytokines has been shown in 
both animal [64] and human [55] sepsis, particularly in the 
hippocampus, hypothalamic and autonomic nuclei. Yet, the 
size  of  the  various  cytokines  is  sufficient  to  prevent  their 
entry into the brain by passive diffusion [11].  
  Three main mechanisms for cytokine entry into the brain 
have  been  described.  Firstly,  the  inflammatory  mediators 
may enter passively into the brain via areas lacking a blood 
brain barrier (BBB), mainly the CVOs. Then, they progress 
in  deeper  brain  regions,  mainly  hypothalamic  nuclei,  the 
hippocampus,  the  amygdala  and  autonomic  nuclei  in  the 
brain stem. Secondly, cytokines may actively cross the BBB 
via specific carriers, particularly in vessels neighboring hy-
pothalamic nuclei and the Locus Coeruleus. Alternately, the 
neurons from the parvocellular and arcuate nuclei may have 
projections  to the median eminence  and may  express  LPS 
receptors on their surface [41]. LPS can also be carried by 
the cerebrospinal fluid to the third ventricle where it crosses 
the ependyma or acts on projections from parvocellular neu-
rons. Active transport into the brain has been demonstrated 
for IL-1 [2], TNF [26] or IL-6 [51]. These cytokines cross 
the BBB via receptor mediated endocytosis, a transport that 
is  likely  regulated  by  both  tissue  and  soluble  factors.  The 
transport of cytokines across the BBB is upregulated during 
inflammation, albeit only about 1% of circulating cytokines 
is  effectively  concerned.  Studies  using  knocked  out  mice 
demonstrated that TNF transport across the BBB is almost 
entirely dependent on its receptors TNFR1 and TNFR2 [46]. 
While TNFR2 has a greater cell surface binding than TNFR1, 
the latter induced faster endocytosis. In addition, TNF asso-
ciated  with  TNFR1  showed  less  degradation  than  with 
TNFR2, and may persist intact in cell’s cytosol for at least 1 
hour. This cytokine is also transported by specific carriers. 
However, only 16% and 50% of the intact cytokine are de-
livered to the cerebrospinal fluid and brain parenchyma, re-
spectively [3]. Yet, this relatively small amount of IL-6 is 
biologically active and contributes to brain ionic homeostasis 
[60]. IL-6 secreted by astroglial cells regulates Na-K-Cl co-
transport  in  brain  microvessel  endothelial  cells.  While  the 
BBB lacks permeation of iv TGF-β1, TGF-β2 can cross the 
BBB after iv administration, via a saturable blood-to-brain 
transport  system  [42].  After  transcytosis,  it  is  distributed 
throughout the brain, with the highest concentrations in the 
hypothalamus.  Altogether,  these  findings  suggest  a  major 
role of the BBB in regulating brain inflammation. There is a 
body of evidence that sepsis is associated with a breakdown 
of the BBB [47], which will ease the entry into the brain of 
pro-inflammatory mediators and other neurotoxic molecules 
(e.g. urea). The breakdown of the BBB is likely mediated by 
IL-1, TNF and NO [39]. 
  Cytokines  such  as  IL-1  can  signal  the  central  nervous 
system through stimulation of the vagus nerve and activation 
of brainstem regions such as the nucleus of the tractus soli-
tarius  [6,63].  Intraperitoneal  injecton  of  bacterial  products 
such as endotoxin elicited a brain response via the subdia-
phragmatic vagus. Indeed, increased in cFos within sensory 
vagal  neurons  followed  the  endotoxin  challenge,  and  vag-
otomy prevented fever  and hyperalgesia induced by  endo-
toxin, TNF or IL-1. This efferent activity in the vagus nerve, 
termed  ‘cholinergic  anti-inflammatory  pathway’,  releases 
acetylcholine in the vicinity of macrophages within the re-
ticulo-endothelial system and leads  to cellular deactivation 
and inhibition of cytokine release [8, 62]. The sympathetic 
and parasympathetic systems are thought to work hand-in-
hand to modulate inflammatory responses. 
  Finally, cytokines like IL-1, IL-6 and TNF may activate 
cerebral endothelial cells or the  microglial (via a  cycloxy-
genase  II  dependent  mechanism)  to  produce  prostaglandin 
E2 which can enter into the brain [35]. In particular, prosta-
glandin  E2  may  activate  preoptic  nuclei  and  induce  fever 
[20].  
CELLS ACTIVATION 
  Microglial  cells  activation  is  the  hallmark  of  brain  in-
flammation [7, 59], and has been documented in sepsis [9]. 
Circulating pro-inflammatory cytokines are major activators 
of microglial cells and astrocytes [22,48]. Cytokines like IL-
1 or TNF injured neurons with subsequent microglial activa-
tion, or may also directly activate these cells, which in turn 
produce pro-inflammatory cytokines, causing a vicious circle 
[57]. Typically, microglial cells activation follows a tempo-
ral  pattern,  expressing  different  markers  allowing  them  to 
first  proliferate,  then  migrate  to  injured  neurons,  the  so-
called synapses stripping, and the nearby parenchyma, where 
they  may  act  as  phagocytes,  and  then  they  downregulate 
themselves  [29].  Astrocytes  are  also  activated  by  the  pro-
inflammatory cytokines, via calcium dependent mechanisms 
[5] and express a number of factors such as signaling recep-
tors,  growth  factors  and  extracellular  matrice  proteins  that 
are important in tissue repair [19]. TGFβ1 is constitutively 
expressed  in normal adult brain [37]. This cytokine  is ex-
pressed by parenchymal microglial cells and exerts a trophic 
and anti-inflammatory effect in the adult CNS [38]. TGFβ1 
interferes with the early phase of microglial activation, de-
creasing cells proliferation and migration, without affecting 
their phagocytic capacity [38]. The crosstalk between micro-
glial  cells  and  astrocytes  is  paramount  in  regulating  brain 
inflammation and communication with neurons [32]. Indeed, 
exposure of cultured astrocytes to LPS or to TNF and IL-1 
activated microglial and caused a dual modulation of con-
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junctional communication released active molecules that can 
communicate with neurons [49].  
  The  cytokines  induced  interaction  between  microglial 
cells and astrocytes, activated  hypothalamic neurons to pro-
duce  and  release  cortisol,  vasopressin  and  catecholamines 
into the circulation, the main stress hormones to restore ho-
meostasis during infection. 
ROLE OF NITRIC OXIDE 
  The synthesis of NO via the inducible isoform of the NO 
synthase (iNOS) seems to be preceded by IL-1 expression in 
the brain. Interestingly, i.p. injection of LPS induces IL-1β 
followed by iNOS mRNA within two hours, peaking in four 
to six hours and then returning to basal values by 24 hours 
[41]. The induction of IL-1β and iNOS occurred in this study 
in the meninges, areas lacking a blood-brain barrier, and also 
in  the  parvocellular  nuclei  and  the  arcuate  nucleus  which 
contain the hypothalamic-releasing and –inhibiting hormone 
producing neurons. A temporal and spatial expression of IL-
1 and iNOS in the CVOs and adjacent structures was also 
demonstrated [31]). Thus, it is likely that delayed synthesis 
of  NO  through  iNOS  activation  prolongs  the  synthesis  of 
hypothalamic hormones induced by LPS [41]. Similar over-
expression of iNOS has been evidenced in walls of vessels 
neighboring  the  parvocellular  nuclei  in  patients  who  died 
from septic shock [54]. Nitric Oxide behaves as a neurotoxic 
effector [18], and was associated with microglial cells and 
neuronal apoptosis in the hypothalamic and autonomic nuclei 
in  both  animals  [43])  and  patients  who  died  from  septic 
shock  [54].  Subsequently,  over-expression  of  iNOS  may 
result  in  decreased  CRF  and  ACTH  [36],  and  vasopressin 
synthesis [25]. Similarly,  excess  in NO via iNOS  induced 
apoptosis in autonomic brain nuclei may be responsible for 
the  loss  in  cardiovascular  variability  in  septic  shock  [54]. 
Finally,  cytokines  via  activation  of  GABAergic  neurons 
block  NO  induced  LHRH  but  not  FSH  release,  inhibit 
GHRH release, and stimulate somatostatin and prolactin re-
lease [40]. The regulatory action of NO is mediated by the 
combined  activation  of  guanylate  cyclase,  cyclooxygenase 
and lipoxygenase [50]. 
  Nitric  oxide  also  blocks  the  mitochondrial  respiratory 
chain (complex I and IV), inducing oxidative stress with the 
formation of peroxinitrite that can trigger premature neuronal 
death [13]. This mechanism of cell death is exacerbated by 
hypoxia and hyperglycemia and may be prevented by the 70-
kDa heat shock proteins [34]. The DNA damage following 
systemic LPS challenge are particularly important within the 
CAP and inner blade region of the hippocampus and the hy-
pothalamus [27]. However, NO might not be able to diffuse 
into brain parenchyma far from vessels and thus its role in 
brain dysfunction following LPS or sepsis might be limited. 
ROLE OF COMPLEMENT 
  The  complement  anaphylatoxin  C5a  is  constitutively 
expressed in neuronal and non neuronal brain cells [45]. Fol-
lowing endotoxin administration, the  C5a receptor became 
up-regulated in a time dependent manner within the cerebral 
endothelium, then microglial cells neighbouring the endothe-
lium and finally in deeper brain parenchyma. The comple-
ment activation has been demonstrated in numerous inflam-
matory and degenerative, acute and chronic, diseases of the 
brain [44]. Following C5a up-regulation, microglial cells are 
recruited and activated to release pro-inflammatory cytoki-
nes, and their phagocytosis capacity is enhanced, and astro-
cytes are activated as well [23]. Subsequently, C5a contrib-
utes to the activation of the stress system. Indeed, systemic 
blockade of C5a reduced LPS-induced neuronal activation in 
the  paraventricular  nuclei  and  amygdala  [14],  and  almost 
fully blunted the pituitary response to peritoneal sepsis [21]. 
Up regulation of C3 induced a breakdown in the BBB and 
increased  gliosis,  water  content,  up  regulated  TLR-4  with 
subsequent alterations in TNF, iNOS and aquaporin 4 [28]. 
Extending these findings, systemic administration of an anti-
C5a neutralising antibody prevented the damage to the BBB 
[21]. Both blocking C5a or its receptor [53], and inhibiting 
the  alternative  complement  pathway,  attenuates  neuronal 
death in experimental traumatic brain injury [33]. 
CONCLUSION 
  The mechanism of brain signaling during sepsis is com-
plex  and  still  poorly  understood.  Following  an  infection, 
homeostasis depends on a tight interaction between the lim-
bic system which contributes to the recognition of the dan-
ger, and the hypothalamic pituitary axis and the noradrener-
gic system which directly modulate metabolic, immune and 
hemodynamic  responses.  The  exact  mechanisms  allowing 
these systems to recognize a peripheral inflammation are not 
fully known and involve the pro-inflammatory cytokines IL-
1 and TNF trafficking across the blood brain barrier, via va-
gal route or via  the  circumventricular organs.  While  these 
cytokines  are  crucial  in  eliciting  an  appropriate  stress  re-
sponse, they trigger the synthesis of the inducible nitric ox-
ide synthase, which may act as a neurotoxic effector impair-
ing  the  neuroendocrine  response.  These  processes  act  via 
autonomic, neurohormonal and humoral structures and path-
ways, highly interconnected to develop an adapted response 
to a septic state, resulting in a balance between pro and anti 
inflammatory response. When this balance is broken with a 
dominating  inflammatory  response,  these  processes  affect 
endothelial  cells,  microglial  cells  and  neurons,  inducing 
blood-brain barrier breakdown, dysfunction of intracellular 
metabolism (mitochondrial dysfunction, and oxidative stress) 
and cell death.  
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